Technical Analysis for BCTX - BriaCell Therapeutics Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.60 | 5.37% | 0.03 |
BCTX closed up 5.37 percent on Wednesday, November 20, 2024, on 21 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Dec 12
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bullish Engulfing | Bullish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | 5.37% | |
| Wide Bands | Range Expansion | 5.37% | |
| Oversold Stochastic | Weakness | 5.37% | |
| NR7 | Range Contraction | 1.23% | |
| Narrow Range Bar | Range Contraction | 1.23% | |
| Inside Day | Range Contraction | 1.23% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 21 hours ago |
| Up 5% | about 21 hours ago |
| Down 1% | about 21 hours ago |
| Rose Above Previous Day's High | about 22 hours ago |
| Up 3% | about 22 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 12/12/2024
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.97 |
| 52 Week Low | 0.4641 |
| Average Volume | 2,942,501 |
| 200-Day Moving Average | 1.55 |
| 50-Day Moving Average | 0.78 |
| 20-Day Moving Average | 0.72 |
| 10-Day Moving Average | 0.63 |
| Average True Range | 0.07 |
| RSI (14) | 36.71 |
| ADX | 23.53 |
| +DI | 16.40 |
| -DI | 28.04 |
| Chandelier Exit (Long, 3 ATRs) | 0.73 |
| Chandelier Exit (Short, 3 ATRs) | 0.78 |
| Upper Bollinger Bands | 0.92 |
| Lower Bollinger Band | 0.51 |
| Percent B (%b) | 0.22 |
| BandWidth | 57.73 |
| MACD Line | -0.07 |
| MACD Signal Line | -0.05 |
| MACD Histogram | -0.0138 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.68 | ||||
| Resistance 3 (R3) | 0.67 | 0.64 | 0.67 | ||
| Resistance 2 (R2) | 0.64 | 0.63 | 0.65 | 0.66 | |
| Resistance 1 (R1) | 0.62 | 0.61 | 0.63 | 0.63 | 0.66 |
| Pivot Point | 0.59 | 0.59 | 0.60 | 0.60 | 0.59 |
| Support 1 (S1) | 0.57 | 0.57 | 0.58 | 0.58 | 0.55 |
| Support 2 (S2) | 0.54 | 0.56 | 0.55 | 0.54 | |
| Support 3 (S3) | 0.52 | 0.54 | 0.54 | ||
| Support 4 (S4) | 0.53 |
